PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 12, 2020SHILAP Revista de lepidopterología4,452 citationsOpen Access

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

JYJing YangYZYa ZhengXGXi Gou

Key Points

  • To evaluate the prevalence of underlying comorbidities among COVID-19 patients and assess their association with disease severity.
  • Conducted a systematic review and meta-analysis of clinical studies assessing underlying diseases in patients with confirmed SARS-CoV-2 infection.
  • Compared comorbidity rates between severe and non-severe patient cohorts.
  • Pre-existing conditions including hypertension, respiratory system disease, and cardiovascular disease are significant risk factors for severe disease compared with non-severe presentations.

Abstract

We assessed the prevalence of comorbidities in the COVID-19 patients and found that underlying disease, including hypertension, respiratory system disease and cardiovascular disease, may be risk factors for severe patients compared with non-severe patients.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yang et al. (2020) studied this question.

synapsesocial.com/papers/69df1331de200760a8614481https://doi.org/10.1016/j.ijid.2020.03.017
Ask AI
Helpful
Bookmark
Share
View Full Paper